Astaxanthin
is a highly value-added keto-carotenoid compound. The
astaxanthin 3S,3′S-isomer
is more desirable for food additives, cosmetics, and pharmaceuticals
due to health concerns about chemically synthesized counterparts with
a mixture of three isomers. Biosynthesis of 3S,3′S-astaxanthin suffers from limited content and productivity.
We engineered Yarrowia lipolytica to
produce high levels of 3S,3′S-astaxanthin. We first assessed various β-carotene ketolases
(CrtW) and β-carotene hydroxylases (CrtZ) from two algae and
a plant. HpCrtW and HpCrtZ from Haematococcus pluvialis exhibited the strongest activity in converting β-carotene
into astaxanthin in Y. lipolytica.
We then fine-tuned the HpCrtW and HpCrtZ transcriptional expression
by increasing the rounds of gene integration into the genome and applied
a modular enzyme assembly of HpCrtW and HpCrtZ simultaneously. Next,
we rescued leucine biosynthesis in the engineered Y.
lipolytica, leading to a five-fold increase in biomass.
The astaxanthin production achieved from these strategies was 3.3
g/L or 41.3 mg/g dry cell weight under fed-batch conditions, which
is the highest level reported in microbial chassis to date. This study
provides the potential for industrial production of 3S,3′S-astaxanthin, and this strategy empowers
us to build a sustainable biorefinery platform for generating other
value-added carotenoids in the future.